Latest filing published 01 Jun 2006 for AVANIR PHARMACEUTICALS, €84k.
Insider track record
No signal scores available.
James E. Berg: trading record in brief
James E. Berg appears in our data through filings on Avanir Pharmaceuticals shares, published by SEC (Form 4). Between 1 March 2006 and 30 May 2006, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 1 June 2006: an option exercise of €84k, in Avanir Pharmaceuticals. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James E. Berg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,500 shares@ US$2.88Class A Common StockSEC:0001186120-06-000036:0
- 750 shares@ US$10.00Class A Common StockSEC:0001209191-06-014769:0
- 2,500 shares@ US$5.88Class A Common StockSEC:0001209191-06-014769:1
3 of 3 declarations
